EPISODE · Aug 30, 2024 · 18 MIN
Updates from the SELECT Trial: Outcomes by Sex | ESC 2024
from JACC This Week
Neha J. Pagidipati, MD, FACC, JACC Associate Editor and Subodh Verma MD, PhD explore a secondary analysis of the SELECT trial, a landmark study investigating the cardiovascular benefits of semaglutide in people with obesity or overweight without diabetes.
NOW PLAYING
Updates from the SELECT Trial: Outcomes by Sex | ESC 2024
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 3, 2026 ·44m
Feb 21, 2026 ·30m
Jan 2, 2026 ·47m